3H-10000

N/A

Report date: 2025/12/04 20:00:08

Base Information

Drug Name3H-10000
Drug Alias Name3H-100003H10000
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Fibroblast Growth Factor Receptor 2b
TargetsFibroblast Growth Factor Receptor 2b
Therapy Area/IndicationsSolid tumoursLung NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator Companies3H Pharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active Companies3H Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A